BOCA RATON, FL, UNITED STATES, March 9, 2026 /EINPresswire.com/ -- With trust in western medicine declining, American ...

China approves Pfizer’s GLP-1 weight-loss drug, expanding competition in the booming obesity treatment market and highlighting rising metabolic health concerns.

People associate ‘Made in China’ with cheap things or mass production. It doesn't mean the quality isn't there.” Designers ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED" or the "Company") (Nasdaq/AIM:HCM; HKEX:13) today announces an update regarding ...

In 2022, Brookins began building an A.I. companion modelled on Geralt of Rivia, a character from a series of fantasy novels ...

China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded ...

Slate Medicines, a new Raleigh biotechnology company developing treatments for migraine and headache disorders, has announced ...

A decade ago, more than 63% of the pharmaceutical giant's revenue was tied up in one drug -- Humira. Granted, it was the ...

February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...

Regeneron Pharmaceuticals (NASDAQ:REGN) said Monday that partner Hansoh Pharmaceutical Group Company Limited reported positive results from a Phase 3 clinical trial evaluating olatorepatide in Chinese ...